Scott Drake is a proven leader in the medical device space. He is currently the President and CEO of ViewRay, an MRI-guided radiation therapy company with leading technology. Previously, Scott was President and CEO of Spectranetics, a publicly traded medical device company. During his six-year tenure, shareholder value increased from approximately $170 million to $2.2 billion when acquired by Royal Philips. Prior to Spectranetics, he spent 17 years in leadership positions within numerous health care business units at Covidien, including President of Covidien’s $1.5 billion Respiratory and Monitoring Solutions Global Business. Drake serves as Chairman of the Board for AtriCure (NASDAQ: ATRC) and as the Chairperson of the AdvaMed Radiation Therapy Sector. He previously served on the Board of Directors for The Zayo Group Holdings, Inc, which was acquired by Digital Colony and EQT for $14.3 billion. In 2014 he was named an Ernst and Young Entrepreneur of the Year.